Connection

Carole Oskeritzian to Interleukin-6

This is a "connection" page, showing publications Carole Oskeritzian has written about Interleukin-6.
Connection Strength

0.449
  1. Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis. J Immunol. 2004 Jan 01; 172(1):593-600.
    View in: PubMed
    Score: 0.194
  2. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol. 1999 Nov 01; 163(9):5105-15.
    View in: PubMed
    Score: 0.145
  3. IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells. Clin Exp Allergy. 2001 Jul; 31(7):1077-85.
    View in: PubMed
    Score: 0.041
  4. TGF-?1 Suppresses IL-33-Induced Mast Cell Function. J Immunol. 2017 08 01; 199(3):866-873.
    View in: PubMed
    Score: 0.031
  5. Anaplasma phagocytophilum infects mast cells via alpha1,3-fucosylated but not sialylated glycans and inhibits IgE-mediated cytokine production and histamine release. Infect Immun. 2011 Jul; 79(7):2717-26.
    View in: PubMed
    Score: 0.020
  6. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. FASEB J. 2009 Oct; 23(10):3506-15.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.